These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34915395)

  • 1. Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia.
    Verlohren S; Brennecke SP; Galindo A; Karumanchi SA; Mirkovic LB; Schlembach D; Stepan H; Vatish M; Zeisler H; Rana S
    Pregnancy Hypertens; 2022 Mar; 27():42-50. PubMed ID: 34915395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women.
    Sovio U; Gaccioli F; Cook E; Hund M; Charnock-Jones DS; Smith GC
    Hypertension; 2017 Apr; 69(4):731-738. PubMed ID: 28167687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis].
    Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M
    Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.
    Andersen LLT; Helt A; Sperling L; Overgaard M
    J Am Heart Assoc; 2021 Sep; 10(17):e021376. PubMed ID: 34459248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany.
    Schlembach D; Hund M; Schroer A; Wolf C
    BMC Health Serv Res; 2018 Aug; 18(1):603. PubMed ID: 30081904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting.
    Zeisler H; Llurba E; Chantraine FJ; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Schoedl M; Grill S; Hund M; Verlohren S
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):367-375. PubMed ID: 30014562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the sFlt-1/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?
    Sabrià E; Lequerica-Fernández P; Ganuza PL; Ángeles EE; Escudero AI; Martínez-Morillo E; Alvárez FV
    Clin Chem Lab Med; 2018 Jan; 56(2):303-311. PubMed ID: 28841572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
    Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
    J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
    Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
    BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal Serum Angiogenic Factor sFlt-1 to PlGF Ratio in Preeclampsia: A Useful Marker for Differential Diagnosis and Prognosis Evaluation in Chinese Women.
    Lou WZ; Jiang F; Hu J; Chen XX; Song YN; Zhou XY; Liu JT; Bian XM; Gao JS
    Dis Markers; 2019; 2019():6270187. PubMed ID: 31396294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study.
    Dröge LA; Perschel FH; Stütz N; Gafron A; Frank L; Busjahn A; Henrich W; Verlohren S
    Hypertension; 2021 Feb; 77(2):461-471. PubMed ID: 33280406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia].
    Bubeníková Š; Cíchová A; Roubalová L; Durdová V; Vlk R
    Ceska Gynekol; 2016; 81(4):272-278. PubMed ID: 27882748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.
    Ohkuchi A; Saito S; Yamamoto T; Minakami H; Masuyama H; Kumasawa K; Yoshimatsu J; Nagamatsu T; Dietl A; Grill S; Hund M
    Hypertens Res; 2021 Jul; 44(7):813-821. PubMed ID: 33727707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia.
    Graupner O; Karge A; Flechsenhar S; Seiler A; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B
    Arch Gynecol Obstet; 2020 Feb; 301(2):375-385. PubMed ID: 31734756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First and Second Trimester Serum sFlt-1/PlGF Ratio and Subsequent Preeclampsia: A Systematic Review.
    Yusuf AM; Kahane A; Ray JG
    J Obstet Gynaecol Can; 2018 May; 40(5):618-626. PubMed ID: 28927814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
    Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
    Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
    Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
    N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.